Understanding Gastrointestinal Involvement in Juvenile Idiopathic Arthritis: A Perspective from Within the Gut

Saskia Ratna Desita; Nadira Muthi Tsania

doi:10.55927/fjst.v4i2.2

Authors

Saskia Ratna Desita Faculty of Medicine, Airlangga University
Nadira Muthi Tsania Faculty of Medicine, Airlangga University

DOI:

https://doi.org/10.55927/fjst.v4i2.2

Keywords:

Gastrointestinal Disease, Juvenile Idiopathic Arthritis , Gut Inflammation

Abstract

Juvenile idiopathic arthritis (JIA) is the most common form of arthritis affecting the pediatric population. Gastrointestinal diseases such as Inflammatory Bowel Disease (IBD) and Celiac Disease (CD) are more prevalent in patients with JIA. Alteration in gut microbiota composition results in immune dysregulation, disruption of the gut mucosal barrier, and altered intestinal functionality. Furthermore, medication commonly prescribed for JIA patients impacts intestinal health. Management strategies have been suggested to address these complications, including proton pump inhibitors (PPIs), folic acid supplementation, and proper nutrition. This literature review aims to explore the mechanisms underlying gastrointestinal involvement in JIA, assess the impact of commonly used medications, and provide insights into the clinical implications and management.

References

Aalto, K., Lahdenne, P., & Kolho, K.-L. (2017). Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use. Pediatric Rheumatology, 15(1), 9. https://doi.org/10.1186/s12969-016-0132-2

Adedokun, S. A., & Olojede, O. C. (2019). Optimizing gastrointestinal integrity in poultry: the role of nutrients and feed additives [Review]. Frontiers in Veterinary Science, 5. https://doi.org/10.3389/fvets.2018.00348

Albokhari, S., & Muzaffer, M. A. (2021). Anemia in juvenile idiopathic arthritis (JIA) and other pediatric rheumatologic diseases: a retrospective study. Open Journal of Rheumatology and Autoimmune Diseases, 11, 188-202. https://doi.org/10.4236/ojra.2021.114019

Amin, T. S., Shenton, S., Mulligan, K., Wedderburn, L. R., Wood, M., VanRooyen, V., & Leone, V. (2015). Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey. Rheumatology, 54(11), 2108-2109. https://doi.org/10.1093/rheumatology/kev259

Armaroli, G., Klein, A., Ganser, G., Ruehlmann, M. J., Dressler, F., Hospach, A., Minden, K., Trauzeddel, R., Foeldvari, I., Kuemmerle-Deschner, J., Weller-Heinemann, F., Urban, A., & Horneff, G. (2020). Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry. Arthritis Research & Therapy, 22(1), 258. https://doi.org/10.1186/s13075-020-02326-5

Asai, S., Nagai, K., Takahashi, N., Watanabe, T., Matsumoto, T., Asai, N., Sobue, Y., Ishiguro, N., & Kojima, T. (2019). Influence of methotrexate on gastrointestinal symptoms in patients with rheumatoid arthritis. Int J Rheum Dis, 22(2), 207-213. https://doi.org/10.1111/1756-185x.13380

Barral Mena, E., García Cárdaba, L. M., Canet Tarrés, A., Enríquez Merayo, E., Cruz Utrilla, A., & de Inocencio Arocena, J. (2020). Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors. Anales de Pediatría (English Edition), 92(3), 124-131. https://doi.org/https://doi.org/10.1016/j.anpede.2019.05.011

Barut, K., Adrovic, A., Şahin, S., & Kasapçopur, Ö. (2017). Juvenile idiopathic arthritis. Balkan Med J, 34(2), 90-101. https://doi.org/10.4274/balkanmedj.2017.0111

Batu, E. D. (2019). Glucocorticoid treatment in juvenile idiopathic arthritis. Rheumatol Int, 39(1), 13-27. https://doi.org/10.1007/s00296-018-4168-0

Bieber, A., Fawaz, A., Novofastovski, I., & Mader, R. (2017). Antitumor necrosis factor-α therapy associated with inflammatory bowel disease: three cases and a aystematic literature review. J Rheumatol, 44(7), 1088-1095. https://doi.org/10.3899/jrheum.160952

Biswas, S., Qureshi, Z. A., Reyes, S., Bodepudi, S. L., & Thomas, S. E. (2018). IBD-associated arthritis misdiagnosed as juvenile idiopathic arthritis: a case report and literature review: 2091. Official journal of the American College of Gastroenterology | ACG, 113, S1188-S1189. https://journals.lww.com/ajg/fulltext/2018/10001/ibd_associated_arthritis_misdiagnosed_as_juvenile.2090.aspx

Cardile, S., Martinelli, M., Barabino, A., Gandullia, P., Oliva, S., Di Nardo, G., Dall'Oglio, L., Rea, F., de'Angelis, G. L., Bizzarri, B., Guariso, G., Masci, E., Staiano, A., Miele, E., & Romano, C. (2016). Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children. World J Gastroenterol, 22(5), 1877-1883. https://doi.org/10.3748/wjg.v22.i5.1877

Dallocchio, A., Canioni, D., Ruemmele, F., Duquesne, A., Scoazec, J.-Y., Bouvier, R., Paraf, F., Languepin, J., Wouters, C., Guillot, M., & Quartier, P. (2010). Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: A French retrospective study. Rheumatology (Oxford, England), 49, 1694-1698. https://doi.org/10.1093/rheumatology/keq136

Dave, M., Rankin, J., Pearce, M., & Foster, H. E. (2020). Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. Pediatric Rheumatology, 18(1), 49. https://doi.org/10.1186/s12969-020-00443-8

De Filippo, C., Di Paola, M., Giani, T., Tirelli, F., & Cimaz, R. (2019). Gut microbiota in children and altered profiles in juvenile idiopathic arthritis. Journal of Autoimmunity, 98, 1-12. https://doi.org/https://doi.org/10.1016/j.jaut.2019.01.001

Falvey, S., Shipman, L., Ilowite, N., & Beukelman, T. (2017). Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis. Pediatric Rheumatology, 15(1), 52. https://doi.org/10.1186/s12969-017-0180-2

Favier, L. A., Taylor, J., Loiselle Rich, K., Jones, K. B., Vora, S. S., Harris, J. G., Gottlieb, B. S., Robbins, L., Lai, J. T., Lee, T., Kohlheim, M., Gill, J., Bouslaugh, L., Young, A., Griffin, N., Morgan, E. M., & Modi, A. C. (2018). Barriers to adherence in juvenile idiopathic arthritis: a multicenter collaborative experience and preliminary results. J Rheumatol, 45(5), 690-696. https://doi.org/10.3899/jrheum.171087

Ferrara, G., Mastrangelo, G., Barone, P., La Torre, F., Martino, S., Pappagallo, G., Ravelli, A., Taddio, A., Zulian, F., Cimaz, R., & On behalf of the Rheumatology Italian Study, G. (2018). Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatric Rheumatology, 16(1), 46. https://doi.org/10.1186/s12969-018-0255-8

Ferrara, G., Pastore, S., Sancin, L., Torelli, L., Radillo, O., Bramuzzo, M., Bibalo, C., Tommasini, A., Ventura, A., & Taddio, A. (2018). Fecal calprotectin to detect inflammatory bowel disease in juvenile idiopathic arthritis. J Rheumatol, 45(10), 1418-1421. https://doi.org/10.3899/jrheum.171200

Fotis, L., Shaikh, N., Baszis, K. W., Samson, C. M., Lev-Tzion, R., French, A. R., & Tarr, P. I. (2017). Serologic evidence of gut-driven systemic inflammation in juvenile idiopathic arthritis. J Rheumatol, 44(11), 1624-1631. https://doi.org/10.3899/jrheum.161589

Garner, A. J., Saatchi, R., Ward, O., & Hawley, D. P. (2021). Juvenile idiopathic arthritis: a review of novel diagnostic and monitoring technologies. Healthcare (Basel), 9(12). https://doi.org/10.3390/healthcare9121683

Gheita, T., Kamel, S., Helmy, N., El-Laithy, N., & Monir, A. (2012). Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria. Clin Rheumatol, 31(2), 363-366. https://doi.org/10.1007/s10067-011-1848-5

Gonzalez, T., Malagon, C., Guarnizo, P., Mosquera, A. C., Chila-Moreno, L., & Romero-Sanchez, C. (2018). Autoantibodies and gastrointestinal symptoms in colombian children with juvenile idiopathic arthritis. Curr Rheumatol Rev, 14(2), 163-171. https://doi.org/10.2174/1573397114666180108110429

Gorczyca, D., Postepski, J., Czajkowska, A., Mariola, P., Prescha, A., Olesińska, E., Gruenpeter, A., Lachór-Motyka, I., & Szponar, B. (2017). The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity. Clinical Rheumatology, 36. https://doi.org/10.1007/s10067-017-3586-9

Harris, J. G., Kessler, E. A., & Verbsky, J. W. (2013). Update on the treatment of juvenile idiopathic arthritis. Current Allergy and Asthma Reports, 13(4), 337-346. https://doi.org/10.1007/s11882-013-0351-2

Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A. I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G. W., Brockmann, K., Aho, V. T. E., Auvinen, P., Maetzler, W., Berg, D., & Scheperjans, F. (2024). Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. Scientific Reports, 14(1), 13513. https://doi.org/10.1038/s41598-024-63893-0

Higuchi, T., Yoshimura, M., Oka, S., Tanaka, K., Naito, T., Yuhara, S., Warabi, E., Mizuno, S., Ono, M., Takahashi, S., Tohma, S., Tsuchiya, N., & Furukawa, H. (2020). Modulation of methotrexate-induced intestinal mucosal injury by dietary factors. Hum Exp Toxicol, 39(4), 500-513. https://doi.org/10.1177/0960327119896605

Hügle, B., Speth, F., & Haas, J.-P. (2017). Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis. Pediatric Rheumatology, 15(1), 16. https://doi.org/10.1186/s12969-017-0147-3

Hügle, B., & van Dijkhuizen, E. H. P. (2020). MTX intolerance in children and adolescents with juvenile idiopathic arthritis. Rheumatology, 59(7), 1482-1488. https://doi.org/10.1093/rheumatology/keaa139

Hutchings, D., Miller, J. A., & Voltaggio, L. (2019). Paradoxical gastrointestinal reactions in patients taking tumor necrosis factor inhibitors: a rare event that broadens the histologic spectrum of medication–associated injury. Human Pathology, 85, 202-209. https://doi.org/https://doi.org/10.1016/j.humpath.2018.11.003

Jacobson, J. L., & Pham, J. T. (2018). Juvenile idiopathic arthritis: a focus on pharmacologic management. J Pediatr Health Care, 32(5), 515-528. https://doi.org/10.1016/j.pedhc.2018.02.005

Kikuchi, H., Oliveira, L. A., Santos-Silva, A. R., Lopes, M. A., Faustino, I. S. P., Teixeira, V. P., & Júnior, J. N. R. A. (2023). Oral ulcerations associated with the use of methotrexate: a series of 4 cases. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 136(1), e66. https://doi.org/10.1016/j.oooo.2023.03.228

Koshi, E. J., Young, K., Mostales, J. C., Vo, K. B., & Burgess, L. P. (2022). Complications of corticosteroid therapy: a comprehensive literature review. J Pharm Technol, 38(6), 360-367. https://doi.org/10.1177/87551225221116266

Kyvsgaard, N., Mikkelsen, T. S., Thastum, M., Christensen, A. E., Wehner, P. S., Nysom, K., & Herlin, T. (2019). Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children. PLoS One, 14(7), e0219539. https://doi.org/10.1371/journal.pone.0219539

Lamot, L., Miler, M., Vukojević, R., Vidović, M., Lamot, M., Trutin, I., Gabaj, N. N., & Harjaček, M. (2021). The increased levels of fecal calprotectin in children with active enthesitis related arthritis and MRI signs of aacroiliitis: the results of a single center cross-sectional exploratory study in juvenile idiopathic arthritis patients [Brief Research Report]. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.650619

Langer, V., Vivi, E., Regensburger, D., Winkler, T. H., Waldner, M. J., Rath, T., Schmid, B., Skottke, L., Lee, S., Jeon, N. L., Wohlfahrt, T., Kramer, V., Tripal, P., Schumann, M., Kersting, S., Handtrack, C., Geppert, C. I., Suchowski, K., Adams, R. H., . . . Stürzl, M. (2019). IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. J Clin Invest, 129(11), 4691-4707. https://doi.org/10.1172/jci124884

Leksell, E., Ernberg, M., Magnusson, B., & Hedenberg-Magnusson, B. (2008). Intraoral condition in children with juvenile idiopathic arthritis compared to controls. Int J Paediatr Dent, 18(6), 423-433. https://doi.org/10.1111/j.1365-263X.2008.00931.x

Liu, L., Liu, S., Wang, C., Guan, W., Zhang, Y., Hu, W., Zhang, L., He, Y., Lu, J., Li, T., Liu, X., Xuan, Y., & Wang, P. (2019). Folate supplementation for methotrexate therapy in patients with rheumatoid arthritis: a systematic review. J Clin Rheumatol, 25(5), 197-202. https://doi.org/10.1097/rhu.0000000000000810

Lovell, D. J., Dare, J. A., Francis-Sedlak, M., Ball, J., LaMoreaux, B. D., Von Scheven, E., Reinhardt, A., Jerath, R., Alpan, O., Gupta, R., Goldsmith, D., Zeft, A., Naddaf, H., Gottlieb, B., Jung, L., & Holt, R. J. (2018). A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis. Pediatric Rheumatology, 16(1), 41. https://doi.org/10.1186/s12969-018-0260-y

Maller, J., Fox, E., Park, K. T., Paul, S. S., Baszis, K., Borocco, C., Prahalad, S., Quartier, P., Reinhardt, A., Schonenberg-Meinema, D., Shipman-Duensing, L., Terreri, M. T., Simard, J., Lavi, I., Chalom, E., Hsu, J., Zisman, D., & Mellins, E. D. (2021). Inflammatory bowel disease in children with systemic juvenile idiopathic arthritis. J Rheumatol, 48(4), 567-574. https://doi.org/10.3899/jrheum.200230

Manatpreeprem, R., Lerkvaleekul, B., & Vilaiyuk, S. (2023). Factors associated with medication adherence among children with rheumatic diseases [Original Research]. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1149320

Martini, G., Meneghel, A., Fastiggi, M., Dell’Apa, F., Vittadello, F., & Zulian, F. (2023). Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study. Pediatric Rheumatology, 21(1), 18. https://doi.org/10.1186/s12969-023-00800-3

Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., & Rotondo, J. C. (2023). Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells, 12(1). https://doi.org/10.3390/cells12010184

Mulligan, K., Kassoumeri, L., Etheridge, A., Moncrieffe, H., Wedderburn, L. R., & Newman, S. (2013). Mothers' reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life. Pediatr Rheumatol Online J, 11(1), 23. https://doi.org/10.1186/1546-0096-11-23

Naddei, R., Di Gennaro, S., Guarino, A., Troncone, R., Alessio, M., & Discepolo, V. (2022). In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study. Pediatr Rheumatol Online J, 20(1), 31. https://doi.org/10.1186/s12969-022-00689-4

Nayak, R. R., Alexander, M., Deshpande, I., Stapleton-Gray, K., Rimal, B., Patterson, A. D., Ubeda, C., Scher, J. U., & Turnbaugh, P. J. (2021). Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. Cell Host & Microbe, 29(3), 362-377.e311. https://doi.org/10.1016/j.chom.2020.12.008

Niyasom, C., Soponkanaporn, S., Vilaiyuk, S., Lertudomphonwanit, C., Getsuwan, S., Tanpawpong, P., Kaewduang, P., & Sobhonslidsuk, A. (2024). Use of transient elastography to assess hepatic steatosis and fibrosis in patients with juvenile idiopathic arthritis during methotrexate treatment. Clinical Rheumatology, 43(1), 423-433. https://doi.org/10.1007/s10067-023-06835-x

Noha Adel, Y., Mai, H., & Azza, E. (2021). Methotrexate hepatotoxicity in children with juvenile idiopathic arthritis: a single-center study. Current Rheumatology Reviews, 17(2), 242-246. https://doi.org/http://dx.doi.org/10.2174/1573397116666201211123142

Onel, K. B., Horton, D. B., Lovell, D. J., Shenoi, S., Cuello, C. A., Angeles-Han, S. T., Becker, M. L., Cron, R. Q., Feldman, B. M., Ferguson, P. J., Gewanter, H., Guzman, J., Kimura, Y., Lee, T., Murphy, K., Nigrovic, P. A., Ombrello, M. J., Rabinovich, C. E., Tesher, M., . . . Reston, J. T. (2022). 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken), 74(4), 521-537. https://doi.org/10.1002/acr.24853

Pichler, J., Ong, C., Shah, N., Sebire, N., Kiparrissi, F., Borrelli, O., Pilkington, C., & Elawad, M. (2016). Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis. Pediatric Research, 79(6), 895-901. https://doi.org/10.1038/pr.2016.27

Poddighe, D., Rakhimzhanova, M., Marchenko, Y., & Catassi, C. (2019). Pediatric celiac disease in Central and East Asia: current knowledge and prevalence. Medicina (Kaunas), 55(1). https://doi.org/10.3390/medicina55010011

Poddighe, D., Romano, M., Dossybayeva, K., Abdukhakimova, D., Galiyeva, D., & Demirkaya, E. (2022). Celiac disease in juvenile idiopathic arthritis and other pediatric rheumatic disorders. J Clin Med, 11(4). https://doi.org/10.3390/jcm11041089

Qian, X., Liu, Y.-X., Ye, X., Zheng, W., Lv, S., Mo, M., Lin, J., Wang, W., Wang, W., Zhang, X., & Lu, M. (2020). Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction. BMC Genomics, 21(1), 286. https://doi.org/10.1186/s12864-020-6703-0

Räisänen, L., Viljakainen, H., & Kolho, K.-L. (2023). Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases [Brief Research Report]. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1157547

Rebane, K., Tuomi, A.-K., Kautiainen, H., Peltoniemi, S., Glerup, M., & Aalto, K. (2022). Abdominal pain in Finnish young adults with juvenile idiopathic arthritis. Scandinavian Journal of Gastroenterology, 57(10), 1189-1194. https://doi.org/10.1080/00365521.2022.2072691

Sadeghi, P., Salari, K., Ziaee, V., Rezaei, N., & Eftekhari, K. (2021). Serological screening of celiac disease in patients with juvenile idiopathic arthritis. Arch Iran Med, 24(10), 783-785. https://doi.org/10.34172/aim.2021.116

Saif, S., Kakalia, S., Kitchlew, R., Khan, H. A., Fida, S., & Siddique, M. (2022). Role of ondansetron in reducing methotrexate intolerance in patients with inflammatory arthritis. J Coll Physicians Surg Pak, 32(10), 1308-1312. https://doi.org/10.29271/jcpsp.2022.10.1308

Shi, C.-l., Zhang, Y., Zhang, Z.-y., Zhou, J., & Tang, X.-m. (2021). Comparative efficacy and safety of non-steroidal anti-inflammatory drugs in patients with juvenile idiopathic arthritis: a systematic review and network meta-analysis. Indian Pediatrics, 58(2), 162-168. https://doi.org/10.1007/s13312-021-2155-0

Shukla, A., Gaur, P., & Aggarwal, A. (2016). Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis. Clin Exp Immunol, 185(3), 301-308. https://doi.org/10.1111/cei.12818

Soliman, Y. A., Hassan, W. A. S., & Elsayed, D. G. (2021). Gastro-intestinal manifestations of pediatric rheumatic diseases. Benha Journal of Applied Sciences, 6(6), 375-383. https://doi.org/10.21608/bjas.2021.214842

Stefanov, S., Ganeva, M., Stoilov, N., Boyadzhieva, V., & Telcharova-Mihaylovska, A. (2018). The role of gut microbiota in juvenile idiopathic arthritis. Biotechnology & Biotechnological Equipment, 32(5), 1081-1086. https://doi.org/10.1080/13102818.2018.1512376

Stoll, M. L., Kumar, R., Morrow, C. D., Lefkowitz, E. J., Cui, X., Genin, A., Cron, R. Q., & Elson, C. O. (2014). Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther, 16(6), 486. https://doi.org/10.1186/s13075-014-0486-0

Tai, F. W. D., & McAlindon, M. E. (2021). Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clinical Medicine, 21(2), 131-134. https://doi.org/https://doi.org/10.7861/clinmed.2021-0039

Tbini, H., Rahmouni, S., Boussaid, S., Ammou, A. B., Jemmali, S., Rekik, S., Zouaoui, K., Sahli, H., & Elleuch, M. (2022). 17 Anemia in juvenile idiopathic arthritis: analysis of associated factors. Rheumatology, 61(Supplement_2). https://doi.org/10.1093/rheumatology/keac496.013

Tena-Garitaonaindia, M., Arredondo-Amador, M., Mascaraque, C., Asensio, M., Marin, J. J. G., Martínez-Augustin, O., & Sánchez de Medina, F. (2022). Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models. Pharmacological Research, 177, 106056. https://doi.org/https://doi.org/10.1016/j.phrs.2022.106056

Tharwat, S., Nassar, M. K., Salem, K. M., & Nassar, M. K. (2024). Extraarticular manifestations of juvenile idiopathic arthritis and their impact on health-related quality of life. Clin Rheumatol, 43(7), 2295-2305. https://doi.org/10.1007/s10067-024-07008-0

Thatayatikom, A., Modica, R., & Leucio, A. D. (2024). Juvenile idiopathic arthritis. In StatPearls (Ed.). StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554605/

Tian, L., Huang, C., Fu, W., Gao, L., Mi, N., Bai, M., Ma, H., Zhang, C., Lu, Y., Zhao, J., Zhang, X., Jiang, N., Lin, Y., Yue, P., Yuan, J., & Meng, W. (2023). Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota [Review]. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1217306

van Dijken, T. D., Vastert, S. J., Gerloni, V. M., Pontikaki, I., Linnemann, K., Girschick, H., Armbrust, W., Minden, K., Prince, F. H. M., Kokke, F. T. M., Nieuwenhuis, E. E. S., Horneff, G., & Wulfraat, N. M. (2011). Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept. The Journal of Rheumatology, 38(7), 1441-1446. https://doi.org/10.3899/jrheum.100809

van Dijkhuizen, E. H. P., Bulatović Ćalasan, M., Pluijm, S. M. F., de Rotte, M. C. F. J., Vastert, S. J., Kamphuis, S., de Jonge, R., & Wulffraat, N. M. (2015). Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study. Pediatric Rheumatology, 13(1), 5. https://doi.org/10.1186/s12969-015-0002-3

van Straalen, J. W., Krol, R. M., Giancane, G., Panaviene, V., Ailioaie, L. M., Doležalová, P., Cattalini, M., Susic, G., Sztajnbok, F. R., Maritsi, D., Constantin, T., Sawhney, S., Rygg, M., Oliveira, S. K., Nordal, E. B., Saad-Magalhães, C., Rubio-Perez, N., Jelusic, M., de Roock, S., . . . Organisation, f. t. P. R. I. T. (2021). Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. Rheumatology, 61(5), 2104-2112. https://doi.org/10.1093/rheumatology/keab678

Verwoerd, A., Ter Haar, N. M., de Roock, S., Vastert, S. J., & Bogaert, D. (2016). The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J, 14(1), 55. https://doi.org/10.1186/s12969-016-0114-4

Wibrand, C., Kyvsgaard, N., Christensen, A. E., & Herlin, T. (2023). The role of liver transaminase levels in methotrexate intolerance in juvenile idiopathic arthritis—a cross-sectional study. Rheumatology International, 43(5), 875-880. https://doi.org/10.1007/s00296-023-05297-3

Wibrand, C., Kyvsgaard, N., Herlin, T., & Glerup, M. (2024). Methotrexate intolerance in juvenile idiopathic arthritis: definition, risks, and management. Pediatric Drugs, 26(5), 479-498. https://doi.org/10.1007/s40272-024-00643-9

Xin, L., He, F., Li, S., Zhou, Z. X., & Ma, X. L. (2021). Intestinal microbiota and juvenile idiopathic arthritis: current understanding and future prospective. World J Pediatr, 17(1), 40-51. https://doi.org/10.1007/s12519-020-00371-3

Yao, T. C., Wang, J. Y., Chang, S. M., Chang, Y. C., Tsai, Y. F., Wu, A. C., Huang, J. L., & Tsai, H. J. (2021). Association of oral corticosteroid bursts with severe adverse events in children. JAMA Pediatr, 175(7), 723-729. https://doi.org/10.1001/jamapediatrics.2021.0433

Yarema, N., Fedortsiv, O., & Palasiuk, B. (2018). Influence of ω-3 polyunsaturated fatty acids on the structure of immunocompetent cell membranes and the parameters of cellular and humoral immunity in children with rheumatoid arthritis [journal article]. Family Medicine & Primary Care Review, 20(1), 78-82. https://doi.org/10.5114/fmpcr.2018.73707

Zandonadi, R. P. (2022). An overview of nutritional aspects in juvenile idiopathic arthritis. Nutrients, 14(20), 4412. https://www.mdpi.com/2072-6643/14/20/4412

Zaripova, L. N., Midgley, A., Christmas, S. E., Beresford, M. W., Baildam, E. M., & Oldershaw, R. A. (2021). Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatric Rheumatology, 19(1), 135. https://doi.org/10.1186/s12969-021-00629-8

Zhou, B., Xia, X., Wang, P., Chen, S., Yu, C., Huang, R., Zhang, R., Wang, Y., Lu, L., Yuan, F., Tian, Y., Fan, Y., Zhang, X., Shu, Y., Zhang, S., Bai, D., Wu, L., Xu, H., & Yang, L. (2018). Induction and amelioration of methotrexate-induced gastrointestinal toxicity are related to immune response and gut microbiota. eBioMedicine, 33, 122-133. https://doi.org/10.1016/j.ebiom.2018.06.029